SARS-CoV-2: Viral Mechanisms and Possible Therapeutic Targets - What to Learn from Rheumatologists

被引：2
|
作者：
Moura, Carlos Antonio [1 ,2 ]
Moura, Carlos Geraldo [1 ,3 ]
Cerqueira De Sant'ana Costa, Ana Luisa [4 ]
机构：
[1] Santo Antonio Hosp, Internal Med Residency Program, Irma Dulces Social Works, Salvador, BA, Brazil
[2] Salvador Univ UNIFACS, Salvador, BA, Brazil
[3] Bahiana Sch Med & Publ Hlth, Salvador, BA, Brazil
[4] Santo Antonio Hosp, Irma Dulces Social Works, Salvador, BA, Brazil
来源：
JOURNAL OF RHEUMATOLOGY | 2020年 / 47卷 / 10期
关键词：
D O I：
10.3899/jrheum.200657
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1588 / 1589
页数：2
相关论文
共 50 条
  • [31] Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential
    Meyer, Bjoern
    Chiaravalli, Jeanne
    Gellenoncourt, Stacy
    Brownridge, Philip
    Bryne, Dominic P.
    Daly, Leonard A.
    Grauslys, Arturas
    Walter, Marius
    Agou, Fabrice
    Chakrabarti, Lisa A.
    Craik, Charles S.
    Eyers, Claire E.
    Eyers, Patrick A.
    Gambin, Yann
    Jones, Andrew R.
    Sierecki, Emma
    Verdin, Eric
    Vignuzzi, Marco
    Emmott, Edward
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [32] What Can We Learn about SARS-CoV-2 Prevalence from Testing and Hospital Data?
    Sacks, Daniel W.
    Menachemi, Nir
    Embi, Peter
    Wing, Coady
    REVIEW OF ECONOMICS AND STATISTICS, 2024, 106 (03) : 848 - 858
  • [33] Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential
    Bjoern Meyer
    Jeanne Chiaravalli
    Stacy Gellenoncourt
    Philip Brownridge
    Dominic P. Bryne
    Leonard A. Daly
    Arturas Grauslys
    Marius Walter
    Fabrice Agou
    Lisa A. Chakrabarti
    Charles S. Craik
    Claire E. Eyers
    Patrick A. Eyers
    Yann Gambin
    Andrew R. Jones
    Emma Sierecki
    Eric Verdin
    Marco Vignuzzi
    Edward Emmott
    Nature Communications, 12
  • [34] Mechanisms of Immunothrombosis by SARS-CoV-2
    Hernandez-Huerta, Maria Teresa
    Perez-Santiago, Alma Dolores
    Perez-Campos Mayoral, Laura
    Sanchez Navarro, Luis Manuel
    Rodal Canales, Francisco Javier
    Majluf-Cruz, Abraham
    Matias-Cervantes, Carlos Alberto
    Perez-Campos Mayoral, Eduardo
    Romero Diaz, Carlos
    Mayoral-Andrade, Gabriel
    Martinez Cruz, Margarito
    Luna Angel, Judith
    Perez-Campos, Eduardo
    BIOMOLECULES, 2021, 11 (11)
  • [35] Drug targets, mechanisms of drug action, and therapeutics against SARS-CoV-2
    Jena, N. R.
    CHEMICAL PHYSICS IMPACT, 2021, 2
  • [36] Unveiling the Pathological Mechanisms of Death Induced by SARS-CoV-2 Viral Pneumonia
    Oprinca, George-Calin
    Mohor, Cosmin-Ioan
    Oprinca-Muja, Alexandra
    Hasegan, Adrian
    Cristian, Adrian-Nicolae
    Fleaca, Sorin-Radu
    Boeras, Ioana
    Cardos, Roxana
    Atasie, Diter
    Mihalache, Manuela
    Mihalache, Cosmin
    Talvan, Elena Teodora
    Mohor, Calin-Ilie
    MICROORGANISMS, 2024, 12 (03)
  • [37] Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism
    Policard, Martine
    Jain, Sidharth
    Rego, Samantha
    Dakshanamurthy, Sivanesan
    VIRUS RESEARCH, 2021, 301
  • [38] T Lymphocytes as Targets for SARS-CoV-2
    Elena M. Kuklina
    Biochemistry (Moscow), 2022, 87 : 566 - 576
  • [39] T Lymphocytes as Targets for SARS-CoV-2
    Kuklina, Elena M.
    BIOCHEMISTRY-MOSCOW, 2022, 87 (06) : 566 - 576
  • [40] The Cholera Epidemics in Hamburg and What to Learn for COVID-19 (SARS-CoV-2)
    Tarnok, Attila
    CYTOMETRY PART A, 2020, 97 (04) : 337 - 339
12345